ATMI Introduces Ready-to-Use, Sterile Pyrofree(R) Vials
"We have come together with D-Lab to offer this comprehensive solution in support of our customers' end goal of advancing patient health and safety," said Senior Vice President and
Pyrogens are a substance that induce rapid onset of fever with the potential to cause sepsis or progressive septic shock if they enter a patient's bloodstream. This makes it critical to ensure that pyrogens are not present in biopharmaceutical products. While difficult, the most common techniques to remove pyrogens are either inactivation or destruction of the molecule through depyrogenation.
"Pyrofree brings several clear benefits including the most cost-effective solution on the market, scalability from small to commercial-scale batches, and availability in both molded and tubular formats," noted Jean-Pascal Zambaux, inventor of Pyrofree and majority owner of D-Lab. "The vials may also be used for commercial safety stocks of injectables, and feature sizes up to 1 liter."
Pyrofree vials are made to withstand the high temperatures during depyrogenation and sterilization. After these steps, the vials are double-vacuum-packed in a PEEK bag for tamper-evidence, as well as to maintain sterility and guarantee no external contact. A third PE/PA film layer is added to the packaging under vacuum in a Class C cleanroom to protect the vials from any breakage during transportation and eliminate the need for a support tray.
Pyrofree vials are currently available for sale. You can learn more about the Pyrofree vials and technology by visiting: http://www.atmi.com/lifesciences/products/pyrofree/
About ATMI LifeSciences
ATMI LifeSciences is an acknowledged technology leader in the field of single-use bioprocess systems and consumables for the pharmaceutical and biopharmaceutical industries. Its innovative, market-leading portfolio of custom-engineered, flexible packaging solutions, single-use storage systems, mixers and bioreactors is driving bioprocess efficiency and delivering value for biopharmaceutical companies around the world. For more information, please visit www.atmi-lifesciences.com.
Disposable-Lab SAS is a pharmaceutical company which develops innovative technologies based on a disposable isolator and disposable process equipment. Disposable-Lab SAS is offering the life sciences industry a new way to manufacture sterile drugs, enabling dramatic reductions in time and costs. Disposable-Lab is located in Bordeaux Montesquieu (
Statements contained herein that relate to
CONTACT: ATMI Contact:
Troy DewarDirector of Investor Relations and Corporate Communications 203.207.9349 firstname.lastname@example.org Media Contact: Beth Willers Impress Labs415.846.9891 email@example.com
News Provided by Acquire Media
$29.63 + 0.12
|Dec 6, 2013
4:00 PM ET
Continental Stock Transfer & Trust Company
17 Battery Place – 8th Floor
New York, NY 10004
Attn. Transfer Department